CVE-2021-25923In OpenEMR, versions 5.0.0 to 6.0.0.1 are vulnerable to weak password requirements as it does not enforce a maximum password length limit.
Updated under an hour ago ()
Does this affect you?
It affects open-emr openemr. Add what you run to find out whether that includes you.
EPSS puts the chance of exploitation in the next 30 days at 1.34%, higher than 71% of scored CVEs.
Do this next
Free account, 1 product
In OpenEMR, versions 5.0.0 to 6.0.0.1 are vulnerable to weak password requirements as it does not enforce a maximum password length limit. If a malicious user is aware of the first 72 characters of the victim user’s password, he can leverage it to an account takeover.
- CVSS
- 8.1 HIGH (v3.1, NVD)CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:H
- Weakness (CWE)
- Not given
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- 1.34% (percentile 71)
- Assigned by
- Mend
- NVD analysis
- Modified
- Record last updated
- Aug 3, 2024
- First seen by InfoSec Signals
- Oct 12, 2026
Affected products
open-emr openemr open-emr:openemr | from 5.0.0 through 6.0.0.1 | NVD |
References
- https://www.whitesourcesoftware.com/vulnerability-database/CVE-2021-25923x-refsource-misc, exploit, third-party-advisory
- https://github.com/openemr/openemr/commit/28ca5c008d4a408b60001a67dfd3e0915f9181e0x-refsource-misc, patch, third-party-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.